WHAT SCIENTISTS SAY ABOUT DPA OMEGA-3
Research: participant ages ranged from 35 to 96 years from 5 countries (Finland, Iceland, Sweden, Singapore, and the United States) with higher circulating omega-3 FAs had a lower risk of suboptimal sleep.
Omega-3 dietary supplements could possibly improve the COVID-19 patient's recovery. Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), present an anti-inflammatory effect that could ameliorate some patients need for intensive care unit (ICU) admission.
A study published in the British Medical Journal found an association between higher blood levels of the long-chain omega-3 fatty acids EPA, DPA, and DHA and “healthy aging.” The authors concluded their findings support guidelines for increased dietary consumption of long-chain omega-3s in older adults.
Omega-3 significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum
Omega-3 FA significantly improved depressive symptoms in perinatal women regardless of pregnant or postpartum and well-tolerated. Furthermore, the omega-3 response was linked to higher EPA proportion in omega-3 formula and mild- to-moderate depression.
Omega-3 polyunsaturated fatty acids (DHA+EPA+DPA) possess properties that may be protective in chronic obstructive pulmonary disease (COPD). Using the Multi-Ethnic Study of Atherosclerosis (MESA), researchers hypothesized that higher plasma levels of n-3 PUFAs would be associated with a slower progression of percent emphysema on CT, a slower decline in lung function, and a lower risk of chronic lower respiratory disease (CLRD) events.